Company Profile

Spun out of the School of Medicine at LSU Health New Orleans, Chosen Diagnostics is a health care delivery company structured around development of two novel biomarker diagnostic kits. The first of those kits is focused on a common gastrointestinal disease in premature infants - a biomarker test to diagnose a common and life-threatening bowel disease in preterm infants offering more accurate results than current options and allows earlier medical intervention. The second is a diagnostic kit to assess how likely a patient is to respond to certain drug treatments. Management indicate the firm's objective as being to improve the delivery of effective health care by directly addressing the personalization of medicines prescribed for - and being used by - the patient.